Browse Category

NYSE:UNH News 18 January 2026 - 24 January 2026

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

XLV fell 0.51% to $157.48 Friday, trailing the S&P 500, which ended flat. Health insurer CEOs faced House scrutiny over rising premiums and consolidation, with UnitedHealth pledging ACA rebates in 2026. UnitedHealth reports earnings Jan. 27, Regeneron on Jan. 30. Corcept Therapeutics jumped 45% after positive ovarian cancer trial results.
UnitedHealth stock price edges up after-hours as ACA rebate pledge keeps UNH in focus

UnitedHealth stock price edges up after-hours as ACA rebate pledge keeps UNH in focus

UnitedHealth shares rose about 0.5% in after-hours trading Friday, closing at $356.26. The move followed CEO Stephen Hemsley’s announcement that the company will rebate profits from its Obamacare plans as Congress scrutinizes insurer practices. Lawmakers questioned UnitedHealth and other major insurers on Capitol Hill over rising costs. Investors await UnitedHealth’s earnings report and 2026 guidance on Jan. 27.
UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth shares rose 0.2% to $355.19 in late morning trading Friday after the company pledged to rebate ACA marketplace profits in 2026. The move follows a contentious Capitol Hill hearing on insurer competition and rising premiums. Investors await UnitedHealth’s January 27 earnings and 2026 outlook for signals on medical costs.
Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

UnitedHealth shares rose 1.96% to $354.47 Thursday as investors focused on the insurer’s plan to rebate ACA profits starting in 2026. CEO Stephen Hemsley faced lawmakers over rising insurance costs, while analysts await the company’s Jan. 27 results and 2026 outlook. ACA premiums are projected to more than double next year, with enrollment expected to fall by two-thirds.
UnitedHealth stock rises as CEO heads to Congress with Obamacare rebate pledge

UnitedHealth stock rises as CEO heads to Congress with Obamacare rebate pledge

UnitedHealth shares rose 1.8% to $353.85 after the company pledged to rebate 2026 ACA marketplace profits amid scrutiny from lawmakers over affordability. Premiums for ACA plans are set to more than double next year, rising to $1,904, according to KFF. Investors await UnitedHealth’s Jan. 27 earnings report for updates on enrollment and policy risks.
UnitedHealth (UNH) stock jumps after ACA rebate pledge — what Wall Street watches next

UnitedHealth (UNH) stock jumps after ACA rebate pledge — what Wall Street watches next

UnitedHealth shares rose 2.8% in after-hours trading Wednesday after CEO Stephen Hemsley pledged to rebate profits from the company’s Affordable Care Act exchange plans. The announcement comes as Congress weighs the future of ACA subsidies, which expired at the end of 2025. Investors await details on the rebate and the company’s Jan. 27 earnings report.
Dow Jones rebounds as Trump rules out force on Greenland; tariffs still hang over Wall Street

Dow Jones rebounds as Trump rules out force on Greenland; tariffs still hang over Wall Street

The Dow Jones rose about 0.6% Wednesday, recovering nearly 297 points after President Trump ruled out using force to acquire Greenland. Tuesday saw the index plunge 870 points following new U.S. tariffs on European goods. Merck and UnitedHealth led early gains, while IBM and 3M dragged on the previous session. Investors await jobless claims data Thursday and the Fed meeting next week.
Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

The Dow Jones rose 203 points to 48,692.15 early Wednesday, rebounding after Tuesday’s 870-point drop triggered by Trump’s tariff threats on eight European countries. Healthcare stocks led gains, with Merck and UnitedHealth adding about 40 points. The Supreme Court began hearing arguments on Trump’s bid to fire Fed Governor Lisa Cook. A Reuters poll showed economists expect the Fed to hold rates steady this quarter.
UnitedHealth stock bucks Wall Street slide as analysts lift targets ahead of Jan. 27 earnings

UnitedHealth stock bucks Wall Street slide as analysts lift targets ahead of Jan. 27 earnings

UnitedHealth Group shares rose 1.3% to $335.30 Tuesday, outperforming a declining market. Evercore ISI initiated coverage with a $400 price target, while Bernstein raised its target to $444. Options pricing indicated increased volatility ahead of UnitedHealth’s Jan. 27 earnings and 2026 guidance. Other managed-care stocks traded mixed.
UnitedHealth stock back in focus: Bernstein sticks with $444 target as UNH earnings near

UnitedHealth stock back in focus: Bernstein sticks with $444 target as UNH earnings near

UnitedHealth shares closed down 2.3% at $331.02 Friday as Bernstein reiterated an Outperform rating and $444 target, citing potential margin recovery in Medicare Advantage and Medicaid. The company reports earnings and 2026 guidance Jan. 27, with investors focused on medical costs and outlook. U.S. lawmakers will question UnitedHealth’s CEO Jan. 22 on coverage affordability. Markets reopen Tuesday after the holiday.
UnitedHealth stock slips into the holiday pause: what UNH investors watch before Jan. 27 guidance

UnitedHealth stock slips into the holiday pause: what UNH investors watch before Jan. 27 guidance

UnitedHealth shares dropped 2.3% to $331.02 Friday, leading healthcare declines before the Martin Luther King Jr. Day market closure. The company faces scrutiny after a Senate report accused it of inflating Medicare Advantage payments, which UnitedHealth denies. Investors await its 2025 results and 2026 guidance, due Jan. 27. A possible sale of Optum UK to TPG remains under negotiation.
1 2 3 4 5 6 11

Stock Market Today

IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Binance scoops up 3,600 more Bitcoin for SAFU as BTC whipsaws after brutal selloff

Binance scoops up 3,600 more Bitcoin for SAFU as BTC whipsaws after brutal selloff

7 February 2026
Binance bought 3,600 bitcoin for its Secure Asset Fund, bringing its holdings to 6,230 BTC after bitcoin rebounded above $70,000 following a sharp drop. The broader crypto market lost about $2 trillion since October, with $1 billion in leveraged bitcoin positions liquidated in 24 hours. Strategy reported a wider Q4 loss as bitcoin fell. Gemini will cut up to 200 jobs and exit the UK, EU, and Australia.
Halma share price: Friday’s lift sets up what investors watch next week

Halma share price: Friday’s lift sets up what investors watch next week

7 February 2026
Halma shares closed up 0.7% at 3,548 pence on Friday, valuing the group at about £13.4 billion. The Bank of England held rates at 3.75% in a split vote, keeping rate-cut speculation in focus. Halma’s next trading update is set for March 12. The FTSE 100 ended the week up 0.6%, lifted by bank stocks.
Diageo share price slips into the weekend as investors eye Feb. 25 results

Diageo share price slips into the weekend as investors eye Feb. 25 results

7 February 2026
Diageo shares closed down 1.48% at 1,760 pence on Friday, trailing a 0.59% gain in the FTSE 100. An updated analyst consensus points to a 2.0% fall in first-half organic net sales ahead of interim results due Feb. 25. Trading volume was light, and the stock remains over 22% below its 52-week high.
Go toTop